Robotik Radikal Prostatektomide Anestezi Deneyimlerimiz

Abstract

Objective: Robotic radical prostatectomy is commonly used in prostat cancer treatment. Anesthesia management in Robot-assisted laparoscopic radical prostatectomi eshasspecialty due to patient' s age and comorbid diseases, positions and durations of the operation. In this retrospective study we aimed to investigate our anesthesia experiences in patients who underwent Robot-assisted laparoscopic .radical prostatectomy and to discuss the current literature. Material and Methods: After approval of ethical committee 50 patients who underwent Robot-assisted laparoscopic radical prostatectomy were investigated between 1 January 2018 and 30 September 2018. Demographic data, ASA scores, comorbidities, intraoperative anesthesia and analgesia management, complications, amounts of fluids and bloods given intravenously, anesthesia duration, surgical duration, duration of intensive care unit and hospital stays were recorded. Results: Average age of the patients was 63.2±6.2 years. Inhalation anesthesia (sevoflurane or desflurane) ± opioid (remifentanil) was the most anesthesia maintenance preffered. 10 (% 20) patient had bradicardia, 2 (%4) patient had hypotension, 2 (% 4) patient received blood transfusion. Drugs used for postoperative analgesia were tramadol, paracetamol, nonsteroidal anti-inflammatory drugs (NSAID), meperedine. All of the patients were extubated in the operating room and were admitted to intensive care unit (ICU). 96 % of patients staye done night in the ICU. Time of hospital stay was 4.02±1.6 days. Conclusion: In Robot-assisted laparoscopic radical prostatectomies anesthesia management is a special process. Taking precautions for complications, choice of suitable anesthetic agents, lung protective strategies, being in concordance with surgical team are essential for anesthesia.